SCHEMBL760966

SCHEMBL760966

CC(C)(C)OC(=O)NCCNc1cccc(I)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.53
MALT1 Q9UDY8 1/20 0.49
BRD4 O60885 2/20 0.46
NQO2 P16083 1/20 0.44
LATS1 O95835 1/20 0.44
SUV39H2 Q9H5I1 2/20 0.43
ADORA3 P0DMS8 3/20 0.42
ADORA2A P29274 3/20 0.42
STK17B O94768 1/20 0.42
STK17A Q9UEE5 1/20 0.42
ADORA1 P30542 1/20 0.41
IDO1 P14902 1/20 0.41
PCSK9 Q8NBP7 1/20 0.41
CKS1B P61024 1/20 0.41
SKP1 P63208 1/20 0.41
SKP2 Q13309 1/20 0.41
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174559 0.82 BCHE (0.54) BCHEMALT1BRD4LATS1STK17B
SCHEMBL13218451 0.81 BCHE (0.47) BCHEMALT1BRD4LATS1SUV39H2
SCHEMBL16790976 0.80 BCHE (0.49) BCHEMALT1BRD4NQO2LATS1
SCHEMBL760341 0.79 CA12 (0.48) BCHEMALT1NQO2STK17BSTK17A
SCHEMBL4491782 0.77 BCHE (0.46) BCHEMALT1BRD4LATS1SUV39H2
SCHEMBL15286381 0.77 BCHE (0.61) BCHEMALT1BRD4NQO2LATS1
SCHEMBL1040727 0.77 BCHE (0.49) BCHEMALT1BRD4NQO2LATS1
SCHEMBL867510 0.76 BCHE (0.52) BCHEMALT1BRD4LATS1ADORA3
SCHEMBL31420894 0.75 BCHE (0.52) BCHEMALT1BRD4LATS1SUV39H2
SCHEMBL3909008 0.75 STK17B (0.55) BCHEMALT1BRD4LATS1SUV39H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 BCHE 2790/4885MALT1 1081/4885BRD4 1433/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 BCHE 2790/4885MALT1 1081/4885BRD4 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.